Plus Therapeutics Announces Selection of “Rhenium (186Re) Obisbemeda” as International Non-Proprietary Name for 186RNL
Plus Therapeutics Announces Selection of “Rhenium (186Re) Obisbemeda” as International Non-Proprietary Name for 186RNL – Nanotechnology News Today – EIN Presswire
Trusted News Since 1995
A service for nanotechnology industry professionals
·
Wednesday, October 26, 2022
·
597,895,728
Articles
·
3+ Million Readers
